Phase 2 study of pretreatment with hydroxyurea prior to induction therapy for patients with newly diagnosed acute myeloid leukemia

Trial Profile

Phase 2 study of pretreatment with hydroxyurea prior to induction therapy for patients with newly diagnosed acute myeloid leukemia

Recruiting
Phase of Trial: Phase II

Latest Information Update: 26 Nov 2016

At a glance

  • Drugs Hydroxycarbamide (Primary)
  • Indications Acute myeloid leukaemia; Leucopenia
  • Focus Therapeutic Use
  • Acronyms PREFACE
  • Most Recent Events

    • 29 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top